Ultragenyx Pharmaceutical Inc. (RARE) quarterly cash flow statement — complete operating, investing & financing history
Ultragenyx Pharmaceutical Inc. (RARE) cash flow statement — 15-year operating, investing & financing cash flows
| Metric | Q2'26 | Q1'26 | Q4'25 | Q3'25 | Q2'25 | Q1'25 | Q4'24 | Q3'24 | Q2'24 | Q1'24 | Q4'23 | Q3'23 | Q2'23 | Q1'23 | Q4'22 | Q3'22 | Q2'22 | Q1'22 | Q4'21 | Q3'21 |
|---|
| Cash from Operations | -97M | -197M | -99.83M | -91.42M | -108.27M | -166.47M | -79.5M | -67M | -76.96M | -190.73M | -83.9M | -117.87M | -116.16M | -156.87M | -90.34M | -95.34M | -77.26M | -117.52M | -54.34M | -59.65M |
| Operating CF Margin % | -45.33% | -144.85% | -48.23% | -57.16% | -65.03% | -119.52% | -48.22% | -48.03% | -52.35% | -175.25% | -65.86% | -120.22% | -107.25% | -156.09% | -87.42% | -105.12% | -86.47% | -147.02% | -65.17% | -73.06% |
| Operating CF Growth % | 10.41% | -18.34% | -25.57% | -36.46% | -40.68% | 12.72% | 5.25% | 43.16% | 33.74% | -21.59% | 7.13% | -23.63% | -50.36% | -33.48% | -66.24% | -59.84% | -18.21% | 26.25% | 12.98% | 3.74% |
| Net Income | -92M | -185M | -128.56M | -180.41M | -114.95M | -151.08M | -133.38M | -133.52M | -131.6M | -170.68M | -123.19M | -159.65M | -159.83M | -163.97M | -151.83M | -245.11M | -158.16M | -152.32M | -122.46M | -73M |
| Depreciation & Amortization | 8M | 8M | 8.79M | 8.61M | -11.77M | 8.99M | 9.08M | 8.76M | 8.86M | 8.85M | 8.22M | 7.19M | 5.36M | 5.24M | 4.96M | 4.69M | 4.48M | 4.09M | 3.53M | 3.22M |
| Stock-Based Compensation | 34M | 30M | 37.29M | 37.01M | 38.53M | 39.92M | 40.16M | 41.57M | 39.37M | 36.93M | 0 | 34.88M | 34.65M | 31.95M | 29.36M | 35.76M | 35.86M | 29.4M | 26.82M | 26.79M |
| Deferred Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -1.62M | -1.26M | 0 | 0 | 0 | 0 | 0 | 0 | 18.21M | 0 |
| Other Non-Cash Items | -18M | 1M | -17.93M | -11.48M | 1.73M | -7.67M | -18.11M | -14.63M | -9.96M | -9.79M | 17.76M | -1.83M | -3.51M | 8.28M | 5.33M | 87.14M | 12.65M | 13M | -1.14M | -19.76M |
| Working Capital Changes | -29M | -51M | 588K | 54.86M | -21.81M | -56.63M | 22.75M | 30.83M | 16.36M | -56.02M | 14.92M | 2.8M | 7.16M | -38.36M | 21.85M | 22.17M | 27.91M | -11.69M | 20.69M | 3.1M |
| Change in Receivables | -62M | 19M | -33.83M | 5.42M | -12.65M | 10.06M | -20.64M | 9.79M | 2.16M | -24.91M | 1.01M | -6.2M | -15.08M | -2.51M | -9.1M | 5.93M | -8.94M | 33K | -3.07M | -693K |
| Change in Inventory | -3M | -4M | 150K | -5.59M | 208K | -763K | -2.46M | -2.5M | -4.13M | -2.12M | -1.96M | -3.47M | -1.66M | 150K | -4.21M | -791K | -3.23M | -1.48M | -990K | 47K |
| Change in Payables | 24M | -57M | 37.01M | 45.12M | -9.68M | -48.45M | 0 | 0 | 25.33M | -35.54M | 17.13M | 7.48M | 11.78M | -35.49M | 35.03M | 11.16M | 0 | -16.16M | 55.91M | 13.45M |
| Cash from Investing | 44M | -49M | -72.25M | 117.18M | 71.17M | 119.89M | 102.73M | -275.5M | 60.56M | 94.44M | -107.02M | 64.3M | 99.42M | 111.3M | -171.6M | -161.86M | 79.17M | -37.36M | 69.06M | -40.76M |
| Capital Expenditures | -1M | -1M | -938K | -1.28M | -2.46M | -1.32M | -654K | -1.62M | -2.01M | -3.21M | -1.6M | -3.69M | -13.94M | -25.03M | -26.97M | -26.05M | -30.92M | -62.18M | -16.05M | -20.56M |
| CapEx % of Revenue | 0.47% | 0.74% | 0.45% | 0.8% | 1.48% | 0.95% | 0.4% | 1.16% | 1.37% | 2.95% | 1.26% | 3.77% | 12.87% | 24.91% | 26.1% | 28.72% | 34.61% | 77.79% | 19.24% | 25.18% |
| Acquisitions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 366K | 0 | 0 | 0 | 79.84M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | -3M | -5M | 273K | -185K | -308K | -15.78M | -127K | -203K | -2.54M | -12.06M | -271K | -428K | -2.9M | -3.95M | -604K | -75.57M | -183K | 2.58M | -80.3M | -487K |
| Cash from Financing | 3M | 0 | 394.19M | 2K | 83.65M | 157K | 3.19M | 11.17M | 384.94M | -58K | 330.61M | 25.23M | 33.02M | -722K | 1.88M | 491.88M | 5.84M | 1.61M | 85.72M | 7.55M |
| Debt Issued (Net) | 0 | 0 | 392M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Equity Issued (Net) | 3M | 0 | 2.19M | 2K | 83.65M | 0 | 0 | 117K | 0 | 0 | 326.46M | 24.79M | 0 | 0 | 0 | 0 | 0 | 1.75M | 78.94M | 0 |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | 0 | 0 | 0 | 157K | 3.19M | 11.06M | 384.94M | -58K | 4.15M | 442K | 33.02M | -722K | 1.88M | 491.88M | 5.84M | -143K | 6.78M | 7.55M |
| Net Change in Cash | -49M | -251M | 221.66M | 26.05M | 49.47M | -44.98M | 23.95M | -330.05M | 367.89M | -97.03M | 140.79M | -29.06M | 16.14M | -46.07M | -258.71M | 233.59M | 6.51M | -153.38M | 100.05M | -93.34M |
| Free Cash Flow | -98M | -198M | -100.77M | -92.7M | -95.73M | -182.8M | -80.16M | -68.61M | -81.47M | -203.94M | -85.5M | -121.57M | -132.6M | -181.9M | -117.31M | -121.39M | -108.18M | -179.71M | -70.39M | -80.21M |
| FCF Margin % | -45.79% | -145.59% | -48.68% | -57.96% | -57.5% | -131.23% | -48.62% | -49.19% | -55.41% | -187.39% | -67.12% | -123.98% | -122.43% | -181% | -113.51% | -133.83% | -121.08% | -224.81% | -84.41% | -98.24% |
| FCF Growth % | -2.37% | -8.32% | -25.71% | -35.11% | -17.5% | 10.37% | 6.25% | 43.56% | 38.56% | -12.11% | 27.11% | -0.15% | -22.57% | -1.22% | -66.66% | -51.34% | -26.63% | -2.24% | 14.28% | -17.92% |
| FCF per Share | -0.96 | -1.97 | -1.01 | -0.93 | -0.97 | -1.90 | -0.84 | -0.72 | -0.94 | -2.42 | -1.05 | -1.70 | -1.87 | -2.58 | -1.67 | -1.73 | -1.55 | -2.59 | -1.03 | -1.18 |
| FCF Conversion (FCF/Net Income) | 1.05x | 1.06x | 0.77x | 0.51x | 0.94x | 1.10x | 0.60x | 0.50x | 0.58x | 1.12x | 0.68x | 0.74x | 0.73x | 0.96x | 0.60x | 0.39x | 0.49x | 0.77x | 0.44x | 0.82x |
| Interest Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |